Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ascentage
Pharma
Takeda, Enhertu, East Asian American execs—Fierce Pharma Asia
Takeda named Julie Kim as its next CEO. AZ and Daiichi's Enhertu nabbed a new FDA nod. East Asian Americans are underrepresented in C-suites. And more.
Angus Liu
Jan 31, 2025 8:53am
Takeda, AZ-Daiichi, Fosun-Henlius—Fierce Pharma Asia
Jan 24, 2025 8:55am
MediLink, Takeda, Ascentage and China NMPA—Fierce Pharma Asia
Jun 21, 2024 8:23am
Takeda circles Ascentage's Scemblix challenger for up to $1.3B
Jun 14, 2024 11:30am
Pfizer, Gilead-Yuhan and more—FiercePharmaAsia
Jan 11, 2019 11:02am
FiercePharmaAsia—Pfizer, China-India alliance, Sinovant and more
Jul 20, 2018 9:58am
